Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes

https://doi.org/10.1016/j.mvr.2004.11.001Get rights and content

Abstract

Pigment epithelium-derived factor (PEDF) is a potent inhibitor of angiogenesis in the mammalian eye, suggesting that loss of PEDF is implicated in the pathogenesis of proliferative diabetic retinopathy. However, a role for PEDF in early diabetic retinopathy remains to be elucidated. Since oxidative stress is thought to be involved in pericyte loss and dysfunction, one of the changes characteristic of early diabetic retinopathy, we investigated whether and how PEDF could protect cultured retinal pericyte against oxidative stress injury. High glucose (30 mM) increased intracellular reactive oxygen species (ROS) generation in pericytes, which was completely blocked by PEDF. High glucose or H2O2 was found to induce growth retardation and apoptotic cell death of pericytes. PEDF completely restored these cytopathic effects on pericytes. An increased ratio of bax to bcl-2 mRNA level with subsequent activation of caspase-3 was observed in high-glucose- or H2O2-exposed pericytes, which was also completely prevented by PEDF. PEDF significantly increased glutathione peroxidase (GPx) mRNA levels and activity in pericytes. Further, PEDF was found to completely inhibit high-glucose- or H2O2-induced increase in a mRNA ratio of angiopoietin-2 to angiopoietin-1 and up-regulation of VEGF mRNA levels in pericytes. PEDF mRNA levels themselves were down-regulated in high-glucose- or H2O2-exposed pericytes. These results demonstrate that PEDF protects against high-glucose- or H2O2-induced pericyte apoptosis and dysfunction through its anti-oxidative properties via GPx induction. Our present study suggests that substitution of PEDF proteins might be a promising therapeutic strategy for treatment of patients with early diabetic retinopathy.

Introduction

Vessels of the microvasculature are composed of only two cell types, endothelial cells (ECs) and pericytes. We have previously shown that pericytes not only regulate growth, but also preserve the prostacyclin-producing ability and protect against lipid-peroxide-induced injury of co-cultured ECs, thus providing a basis for understanding why diabetic retinopathy develops subsequent to pericyte loss (Yamagishi et al., 1993a, Yamagishi et al., 1993b, Yamagishi et al., 1997). Pericyte loss and dysfunction have been considered one of the earliest hallmarks of diabetic retinopathy, and precede the characteristic retinal vascular changes in human diabetes (Cogan et al., 1961, Hammes et al., 2002, Podestá et al., 2000, Yamagishi et al., 1999, Yamagishi et al., 2002a, Yamagishi et al., 2002b, Yamagishi et al., 2002c, Yamagishi et al., 2003a).

Pigment epithelium-derived factor (PEDF), a glycoprotein that belongs to the superfamily of serine protease inhibitors, was first identified as a retinal pigment epithelium-derived protein with neuronal differentiating activity in human retinoblastoma cells (Tombran-Tink et al., 1991). Recently, PEDF has been shown to have potent anti-angiogenic activity in cell culture and animal models; PEDF inhibited retinal EC growth and migration and suppressed ischemia-induced retinal neovascularization (Dawson et al., 1999, Duh et al., 2002). PEDF is a natural extracellular component of the retina and has been found in the vitreous and aqueous humors (Becerra, 1997, Wu et al., 1995). Further, recently, decreased levels of PEDF were reported in the ocular fluids of patients with angiogenic eye diseases (Spranger et al., 2001). These observations support the concept that a loss of PEDF in the eye is functionally important in the pathogenesis of proliferative diabetic retinopathy. However, a role for PEDF in early phase of diabetic retinopathy remains to be elucidated.

We have previously shown that high glucose, fatty acids, or advanced glycation end products (AGEs) increase intracellular reactive oxygen species (ROS) generation and subsequently induce apoptotic cell death in retinal pericytes, thus suggesting a pathological involvement of oxidative stress in the development of early diabetic retinopathy (Amano et al., 2002, Yamagishi et al., 1995, Yamagishi et al., 2002a, Yamagishi et al., 2002b, Yamagishi et al., 2002c). Furthermore, recent studies have shown that vascular endothelial growth factor (VEGF) and angiopoietin (ang) are major regulators of vascular integrity and involved in diabetic retinopathy as well (Lu and Adamis, 2002). Therefore, in this study, we investigated whether and how PEDF could inhibit high-glucose- or H2O2-induced apoptotic cell death of cultured retinal pericytes. We further studied effects of PEDF on the above angiogenesis-related gene expression in high-glucose- or H2O2-exposed pericytes.

Section snippets

Materials

d-glucose was purchased from Wako Pure Chemical Industries (Osaka, Japan). Thenoyltrifluoroacetone (TTFA), carbonyl cyanide m-chlorophenylhydrazone (CCCP), N-acetylcysteine (NAC) and glutathione peroxidase (GPx) cellular activity assay kit were purchased from Sigma (St. Louis, MO, USA). H2O2 was purchased from Mitsubishi Gas Chemical Company, Inc. (Tokyo, Japan). Protease inhibitor cocktails were from Nakalai Tesque (Kyoto, Japan). [3H]Thymidine was from Amersham Pharmacia Biotech

Effects of PEDF on intracellular ROS generation in high-glucose-exposed pericytes

We have previously shown that mitochondrial overproduction of ROS is involved in various hyperglycemia-induced abnormalities in ECs (Brownlee, 2001, Nishikawa et al., 2000). So, we first investigated whether high glucose stimulated pericyte ROS production from mitochondrial electron transport system. TTFA, an inhibitor of complex II, or CCCP, an uncoupler of oxidative phosphorylation that abolishes the mitochondrial membrane proton gradient, was found to completely prevent the effects of high

Discussion

In the present study, we demonstrated for the first time that PEDF significantly prevented the high-glucose- or H2O2-induced decrease of the viable cell number and DNA synthesis as well as the increase of apoptotic cell death of retinal pericytes. The present study has extended our previous works, which showed the cytoprotective effects of PEDF on AGE-exposed pericytes (Yamagishi et al., 2002d). We have previously shown that high glucose, fatty acids or AGEs cause apoptotic cell death of

Perspective

There is a growing body of evidence that the generation of ROS is increased in diabetes (Bonnefont-Rousselot, 2002, Spitaler and Graier, 2002, Yamagishi et al., 2001). We have previously shown that high-glucose-induced mitochondrial overproduction of superoxide serves as a causal link between elevated glucose and hyperglycemic vascular damage in ECs (Brownlee, 2001, Nishikawa et al., 2000). In the present study, we found that mitochondrial electron transport chain derived ROS mediated the

Acknowledgments

This work was supported in part by Grants of Venture Research and Development Centers from the Ministry of Education, Culture, Sports, Science and Technology, Japan (S. Yamagishi).

References (52)

  • Y.Q. Wu et al.

    Identification of pigment epithelium-derived factor in the interphotoreceptor matrix of bovine eyes

    Protein Expression Purif.

    (1995)
  • S. Yamagishi et al.

    Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells

    Biochem. Biophys. Res. Commun.

    (1993)
  • S. Yamagishi et al.

    Endothelin 1 mediates endothelial cell-dependent proliferation of vascular pericytes

    Biochem. Biophys. Res. Commun.

    (1993)
  • S. Yamagishi et al.

    Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy

    Biochem. Biophys. Res. Commun.

    (1995)
  • S. Yamagishi et al.

    Advanced glycosylation end products stimulate the growth but inhibit the prostacyclin-producing ability of endothelial cells through interactions with their receptors

    FEBS Lett.

    (1996)
  • S. Yamagishi et al.

    Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor

    J. Biol. Chem.

    (1997)
  • S. Yamagishi et al.

    Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes

    Biochem. Biophys. Res. Commun.

    (2002)
  • S. Yamagishi et al.

    Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties

    Biochem. Biophys. Res. Commun.

    (2002)
  • S. Yamagishi et al.

    Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells

    J. Biol. Chem.

    (2002)
  • S. Yamagishi et al.

    Advanced glycation end products inhibit de novo protein synthesis and induce TGF-beta overexpression in proximal tubular cells

    Kidney Int.

    (2003)
  • J.M. Adams et al.

    The Bcl-2 protein family: arbiters of cell survival

    Science

    (1998)
  • S.P. Becerra

    Structure–function studies on PEDF. A noninhibitory serpin with neurotrophic activity

    Adv. Exp. Med. Biol.

    (1997)
  • L.E. Benjamin et al.

    A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF

    Development

    (1998)
  • E. Beltramo et al.

    Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose

    Diabetes Metab. Res. Rev.

    (2004)
  • D. Bonnefont-Rousselot

    Glucose and reactive oxygen species

    Curr. Opin. Clin. Nutr. Metab. Care

    (2002)
  • M. Brownlee

    Biochemistry and molecular cell biology of diabetic complications

    Nature

    (2001)
  • Cited by (102)

    • Antioxidant supplementation in diabetic retinopathy

      2020, Diabetes: Oxidative Stress and Dietary Antioxidants
    • Functional role of peroxiredoxin 6 in the eye

      2018, Free Radical Biology and Medicine
    • MITF acts as an anti-oxidant transcription factor to regulate mitochondrial biogenesis and redox signaling in retinal pigment epithelial cells

      2018, Experimental Eye Research
      Citation Excerpt :

      In fact, the levels of nuclear factor, erythroid 2-like 2 (NFE2L2, also named NRF2), apurinic/apyrimidinic endodeoxyribonuclease 1 (APE-1), pigment epithelium-derived factor (PEDF), peroxisome proliferator-activated receptor-coactivator 1α (PGC1α), heme oxygenase-1 (HMOX1), peroxiredoxin 3 (PRDX3), superoxide dismutases (SOD1) and glutathione peroxidase-1 (GPX1) were all dramatically increased in MITF overexpressing cells (Fig. 3A). Interestingly, in previous studies, NRF2, SOD1, APE-1, PEDF and PGC1α have been identified to be closely correlated with mitochondrial anti-oxidant functions (Amano et al., 2005; Scarpulla, 2011; St-Pierre et al., 2006; Tomkinson et al., 1988; Wang et al., 2015). The results suggest, therefore, that MITF might promote an anti-oxidant activity by regulating mitochondrial functions in RPE cells.

    View all citing articles on Scopus
    View full text